Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of tyrosine kinase inhibitors. It plays an important role in creating active pharmaceutical ingredients (APIs) for targeted cancer therapies. Its structure allows for selective modification, making it valuable in drug design for oncology and signaling pathway modulation. Commonly utilized in research and industrial settings for building quinazoline-based compounds with biological activity.